As of 2026-04-05, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (22.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -219.4%.
The range of the Relative Valuation is (19.54) - (26.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 18.9x | 16.0x |
| Forward P/E multiples | 12.4x - 18.0x | 14.8x |
| Fair Price | (19.54) - (26.58) | (22.69) |
| Upside | -202.8% - -239.9% | -219.4% |
| Date | P/E |